Revvity, Inc. (NYSE:RVTY) Position Boosted by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. grew its stake in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 91.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 234,625 shares of the company's stock after buying an additional 111,937 shares during the period. Tocqueville Asset Management L.P. owned 0.19% of Revvity worth $26,186,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the stock. Victory Capital Management Inc. lifted its stake in shares of Revvity by 4.5% during the 3rd quarter. Victory Capital Management Inc. now owns 59,860 shares of the company's stock worth $7,647,000 after purchasing an additional 2,582 shares during the period. Metis Global Partners LLC lifted its position in Revvity by 6.5% during the third quarter. Metis Global Partners LLC now owns 7,825 shares of the company's stock worth $1,000,000 after buying an additional 481 shares during the period. CIBC Asset Management Inc grew its holdings in Revvity by 8.2% in the 3rd quarter. CIBC Asset Management Inc now owns 17,993 shares of the company's stock valued at $2,299,000 after buying an additional 1,368 shares during the period. Empirical Finance LLC increased its stake in shares of Revvity by 2.0% during the 3rd quarter. Empirical Finance LLC now owns 4,237 shares of the company's stock valued at $541,000 after acquiring an additional 85 shares during the last quarter. Finally, Empowered Funds LLC purchased a new position in shares of Revvity during the 3rd quarter worth about $227,000. 86.65% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Revvity

In related news, insider Joel S. Goldberg sold 15,170 shares of the stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the sale, the insider now owns 33,400 shares of the company's stock, valued at $4,232,782. This trade represents a 31.23 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Tajinder S. Vohra sold 5,492 shares of the business's stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total transaction of $641,520.52. Following the transaction, the insider now directly owns 19,652 shares of the company's stock, valued at $2,295,550.12. The trade was a 21.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.60% of the company's stock.

Remove Ads

Revvity Stock Up 0.2 %

Shares of RVTY traded up $0.20 during midday trading on Friday, hitting $107.18. The company had a trading volume of 1,281,272 shares, compared to its average volume of 970,051. The stock has a market cap of $12.88 billion, a price-to-earnings ratio of 48.50, a PEG ratio of 3.82 and a beta of 1.06. The company's 50 day moving average price is $116.57 and its 200 day moving average price is $117.66. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. Revvity, Inc. has a 52 week low of $97.32 and a 52 week high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same period last year, the company earned $1.25 earnings per share. On average, equities research analysts predict that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Friday, April 18th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.26%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity's dividend payout ratio (DPR) is presently 12.67%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on RVTY. Barclays upped their price target on shares of Revvity from $135.00 to $140.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Sanford C. Bernstein lowered Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 target price on the stock. in a research report on Friday, January 10th. Bank of America raised Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price target for the company in a research report on Friday, December 13th. KeyCorp raised their price objective on Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Finally, Raymond James reiterated an "outperform" rating and set a $145.00 target price (up previously from $140.00) on shares of Revvity in a report on Monday, February 3rd. Four investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $136.25.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.